MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Clinical trial NCT07335601 updates: 1. completion date: 2027-12-01 → 2029-03-01 2. primary completion date: 2027-07-01 → 2028-08-01 3. enrollment: not set → 120 participants
Clinical trial NCT07335601 updates: 1. completion date: 2027-12-01 → 2029-03-01 2. primary completion date: 2027-07-01 → 2028-08-01 3. enrollment: not set → 120 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical